100GC® Mycoplasma Standards

100GC® Mycoplasma Standards
Product Description

100GC® Mycoplasma Standards are non-infectious, purified nucleic acid reference materials with a defined target amount of ≤100 genome copies (GC). They are specifically designed for the validation, verification, and routine performance monitoring of NAT-based mycoplasma detection methods in regulated and research environments. The standards support matrix-specific validation, determination of the limit of detection (LoD), method suitability testing, and use as external positive controls (EPC) in PCR-based mycoplasma assays. They are compatible with PCR, qPCR, RT-qPCR, and digital PCR workflows and support compliance with EP 2.6.7 (12.2), USP <77>, and JP 18 G3 requirements. The lyophilized, ready-to-use format simplifies handling and improves stability during storage and transport. As non-infectious standards, 100GC® Mycoplasma Standards provide a safe and practical solution for regulated pharmaceutical quality control, ATMP testing, and routine laboratory applications.

Minerva Biolabs GmbH

  • Country/Region:
    Germany
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Technology
Specifications
  • Details
    • Non-infectious mycoplasma reference materials 
    • Defined concentration of ≤100 genome copies (GC) 
    • Designed for NAT-based mycoplasma testing 
    • Suitable for PCR, qPCR, RT-qPCR, dPCR, and ddPCR workflows 
    • Supports determination and verification of limit of detection (LoD) 
    • Can be used as External Positive Control (EPC) 
    • Suitable as Extraction and Inhibition Control (EIC) 
    • Supports matrix-specific validation and method suitability testing
    •  Lyophilized, ready-to-use format 
    • Available for relevant Mollicutes species listed in pharmacopoeias 
    • EP 2.6.7 (12.2), USP <77>, and JP 18 G3 compliant 
    • Suitable for pharmaceutical QC and ATMP applications
  • Selling Points
    Product Features;
    • EP 2.6.7 (12.2)- and USP <77>-compliant reference standards
    • Defined concentration of ≤100 genome copies (GC) 
    • Non-infectious and safe laboratory handling 
    • Suitable for use as External Positive Control (EPC) 
    • Supports standardized and regulatory-compliant NAT workflows 
    • Compatible with PCR, qPCR, and dPCR methods 
    • Lyophilized ready-to-use format for easy handling and high stability 
    • Suitable for GMP/QC laboratories and pharmaceutical quality control 
    • Available for multiple pharmacopoeia-relevant mycoplasma species
  • Model
    Genome Copy-Based Mycoplasma Reference Standards

Minerva Biolabs GmbH

  • Country/Region:
    Germany
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Technology

More Products from Minerva Biolabs GmbH (4)

  • MiQuant® AAV ITR 2/6 – dPCR

    Product MiQuant® AAV ITR 2/6 – dPCR

    The MiQuant® AAV ITR 2/6 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

    This kit provides a primer/probe mix that enables specific detection of AAV genotypes 2 and 6 by amplifying the respectiv...
  • MiQuant® AAV ITR 5 – dPCR

    Product MiQuant® AAV ITR 5 – dPCR

    The MiQuant® AAV ITR 5 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

    This kit provides a primer/probe mix that enables specific detection of AAV genotype 5 by amplifying the respective inverte...
  • MiQuant® Residual DNA HEK-293 – dPCR

    Product MiQuant® Residual DNA HEK-293 – dPCR

    The MiQuant® Residual DNA HEK-293 – dPCR is suitable for the quantitative detection of residual DNA from host cells in chemical and biological matrices. This kit contains a specific primer/probe mix and provides an open platform solution for use on various dPCR instruments (QIAcuity®, ddPCR™, Quant...
  • Venor® Mycoplasma qPCR

    Product Venor® Mycoplasma qPCR

    Venor® Mycoplasma qPCR is a validated real-time RT-qPCR kit for the rapid, sensitive, and reliable detection of mycoplasma contamination in cell cultures, biopharmaceutical products, and advanced therapy medicinal products (ATMPs). The assay detects both RNA and DNA targets, providing enhanced sensitivity ...

Minerva Biolabs GmbH resources (2)

  • News Minerva Biolabs Supports Compliance with the Updated EP 2.6.7 Requirements

    The revised EP 2.6.7 chapter introduces new expectations for NAT-based mycoplasma testing. With validated PCR assays, extraction kits, and reference standards, Minerva Biolabs offers comprehensive solutions to help laboratories efficiently implement and validate compliant workflows according to the latest European Pharmacopoeia requirements.
  • Brochure Minerva Biolabs Company Brochure

    Discover Minerva Biolabs’ portfolio of mycoplasma detection and cell culture contamination control solutions for pharmaceutical, biotechnology, and research applications.